References
- Barbieri R. L., Smith S., Ryan K. J. The role of hyperinsuline-mia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril. 1988; 50: 197
- Pasquali R., Venturoli S., Paradisi R., Capelli M., Parenti M., Melchionda N. Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm. Metab. Res. 1982; 14: 284
- Burghen G. A., Givens J. R., Kitabchi A. E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1980; 50: 113
- Chang R.J., Nakarnura R. M., Judd H. L., Kaplan S. A. Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1983; 57: 356
- Geffner M. E., Kaplan S.A., Bersch N., Golde D. W., Landaw E. M., Chang R. J. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil. Steril. 1986; 45: 327
- Giugliano D., Torella R., Lefebvre P. J., D'Onofrio F. D. Opioid peptides and metabolic regulation. Diabetologia 1988; 31: 3
- Reid R. L., Yen S. S. C. b˜-endorphin stimulates the secretion of insulin and glucagon in humans. J. Clin. Endocrinol. Metab. 1981; 52: 592
- Scavo D., Facchinetti F., Barletta C., Petraglia F., Buzzetti R., Monaco M., Giovanni C., Genazzani A. R. Plasma beta-endorphin in response to oral glucose tolerance test in obese patients. Horm. Metab. Res. 1987; 19: 204
- Givens J. R., Wiedemann E., Andersen R. N., Kitabchi A. E. b˜-endorphin and b˜-lipotropin plasma levels in hirsute women: correlation with body weight. J. Clin. Endocrinol. Metab. 1980; 50: 975
- Laatikainen T., Salminen K., Virtanen T., Apter D. Plasma b˜-endorphin, b˜-lipotropin and corticotropin in polycystic ovarian disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 1987; 24: 327
- Laatikainen T., Virtanen T., Apter D. Plasma imrnuno-reactive b˜-endorphin in exercise-associated amenorrhea. Am. J. Obstet. Gynecol. 1986; 154: 94
- Siegberg R., Nilsson C. G., Stenrnan U.-H., Widholm O. Endocrinologic features of oligornenorrheic adolescent girls. Fertil. Steril. 1986; 46: 852
- Facchinetti F., Grasso A., Petraglia F., Parrini D., Volpe A., Genazzani A. R. Impaired circadian rhythmicity of b˜-lipotrophin, b˜-endorphin and ACTH in heroin addicts. Acta Endocrinol. 1984; 105: 149
- Getto C. J., Fullerton D. T., Carlson I. H. Plasma immuno-reactive beta-endorphin response to glucose ingestion in human obesity. Appetite 1984; 5: 329
- Orwoll E. S., Kendall J. W. b˜-endorphin and adrenocortico-trophin in extrapituitary sites: gastrointestinal tract. Endocrinology 1980; 107: 438
- Bruni J. F., Watkins W. B., Yen S. S. C. b˜-endorphinin the human pancreas. J. Clin. Endocrinol. Metab. 1979; 49: 649
- Recant L., Voyles N., Wade A., Awoke S., Bathena S. Study on the role of the opiates in two forms of genetic obesity: ob/ob mouse and fa/fa rats. Horm. Metab. Res. 1983; 15: 589
- Giugliano D., Salvatore T., Cozzolino D., Ceriello A., Torella R., D'Onofrio F. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to b˜-endorphin in human diabetes mellitus. J. Clin. Endocrinol. Metab. 1987; 64: 1122
- Givens J. M., Kurtz B. R., Kitabchi A. E., Bittle J. B., Karas J. G., Mitchell J. A., Howes J. F. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. J. Clin. Endocrinol. Metab. 1987; 64: 377